Abstract
Chromatin, a huge polymer of nucleosomes, has been implicated as an important target of autoantibodies in idiopathic and drug-induced lupus for decades, but the antigenicity of chromatin has only recently been dissected. IgG reactivity with the (H2A-H2B)-DNA complex, a subunit of the nucleosome, is present in the majority of patients with systemic lupus erythematosus, in >90% of patients with lupus induced by procainamide and in individual patients with lupus induced by a variety of other drugs, but is not seen in people taking these medications who are clinically asymptomatic. Anti-[(H2A-H2B)-DNA] accounted for the bulk of the anti-chromatin activity in drug-induced lupus. The earliest detectable autoantibody in lupus-prone mice recognized similar epitopes in the (H2A-H2B)-DNA subnucleosome complex; as the immune response progressed, native DNA and other constituents of chromatin became antigenic. The importance of chromatin-reactive T cells in the anti-[(H2A-H2B)-DNA] response is suggested by the presence of somatic mutations in antibody VH and VL regions, their perdominant IgG isotype and the similarity in kinetics of their production to that of conventional T cell dependent antigens. Together with the serologic data from human lupus-like disease, these results are consistent with chromatin being a common stimulant for both B and T cells. While chromatin-reactive antibodies are closely associated with systemic disease and have recently been implicated in glomerulonephritis in SLE, the absence of renal disease in drug-induced lupus indicates that additional abnormalities are required to manifest the serious pathogenic potential of anti-[(H2A-H2B)-DNA] antibodies.
Similar content being viewed by others
Abbreviations
- APC:
-
antigen present cells
- DIL:
-
drug-induced lupus
- ELISA:
-
enzyme-linked immunosorbent assay
- GBM:
-
glomerular basement membrane
- [(H2A-H2B)-DNA]:
-
an intermolecular complex consisting of DNA and a dimer of histones H2A and H2B
- nDNA:
-
native (double-stranded) DNA
- SLE:
-
systemic lupus erythematosus
References
Hargraves MM, Richmond H & Morton R (1948) Proc. Staff Mtg. Mayo Clinic 23: 25–28
Holman H & Deicher HR (1959) J. Clin. Invest. 38: 2059–2072
Friou GJ (1958) J. Immunol. 80: 476–481
Kunkel HG, Holman HR & Deicher HRG (1960) Ciba Foundation Symposium on Cellular Aspects of Immunity (pp 429–437) Ciba, Basel.
Stollar BD (1969) J. Immunol. 103: 804–808
Tan EM, Robinson J & Robitaille P (1976) Scand. J. Immunol. 5: 811–818
Fritzler MJ & Tan EM (1978) J. Clin. Invest. 62: 560–567
McGhee JD & Felsenfeld G (1980) Annu. Rev. Biochem. 49: 1115–1156
Rekvig OP & Hannestad K (1980) J. Exp. Med. 152: 1720–1733
Rubin RL, Joslin FG & Tan EM (1982) Arthritis Rheum. 25: 779–782
Arents G, Burlingame RW, Wang B-C, Love WE & Moudrianakis EN (1991) Proc. Natl. Acad. Sci. USA 88: 10148–10152
Arents G & Moudrianakis EN (1993) Proc. Natl. Acad. Sci. USA 90: 10489–10493
Struck MM, Klug A & Richmond TJ (1992) J. Mol. Biol. 224: 253–264
Pederson DS, Thoma F & Simpson RT (1986) Annu. Rev. Cell Biol. 2: 117–147
Wyllie AH, Kerr JFR & Currie AR (1980) Int. Rev. Cytol. 68: 251–306
Robitaille P & Tan EM (1973) J. Clin. Invest. 52: 316–323
Karsh J, Halpert SP, Anken M, Klima E & Steinberg AD (1982) Int. Arch. Allergy Appl. Immunol. 68: 60–69
Burlingame RW, Boey ML, Starkebaum G & Rubin RL (1994) J. Clin. Invest. 94: 184–192
Chabre H, Amoura Z, Piette J-C, Godeau P, Bach J-F & Koutouzov S (1995) Arthritis Rheum. 38: 1485–1491
Lefkowith JB, Kiehl M, Rubenstein J, DiValerio R, Bernstein K, Kahl L, Rubin RL & Gourley M (1996) J. Clin. Invest. 98: 1373–1380
Burlingame RW, Rubin RL, Balderas RS & Theofilopoulos AN (1993) J. Clin. Invest. 91: 1687–1696
Amoura Z, Chabre H, Koutouzov S, Lotton C, Cabrespines A, Bach J & Jacob L (1994) Arthritis Rheum. 37(11): 1684–1688
Losman MJ, Fasy TM, Novick KE & Monestier M (1992) J. Immunol. 148: 15
Losman MJ, Fasy TM, Novick KE & Monestier M (1993) Int. Immunol. 5: 513–523
Mohan C, Adams S, Stanik V & Datta SK (1993). J. Exp. Med. 177: 1367–1381
Duncan SR, Rubin RL, Burlingame RW, Sinclair SB, Pekny KW & Theofilopoulos AN (1996) Clin. Immunol. Immunopath. 79: 171–181
Gleichmann E, Pals ST, Rolink AG, Radaskiewicz T & Gleichmann H (1984) Immunol. Today 5: 324–332
Pollard KM, Chan EKL, Rubin RL & Tan EM (1987) Clin. Immunol. Immunopathol. 44: 31–40
Rubin RL, Tang F Tsay G & Pollard KM (1990) Clin. Immunol. Immunopathol. 54: 320–332
Goodnow CC, Crosbie J, Jorgensen H, Brink RA & Basten A (1989) Nature 342: 385–391
Burlingame RW & Rubin RL (1991) J. Clin. Invest. 88: 680–690
Mongey A-B, Donovan-Brand R, Thomas TJ, Adams LE & Hess EV (1992) Arthritis Rheum. 35: 219–223
Rubin RL, Burlingame RW, Arnott JE, Totoritis MC, McNally EM & Johnson AD (1995) J. Immunol. 154: 2483–2493
Rubin RL, Bell SA & Burlingame RW (1992) J. Clin. Invest. 90: 165–173
Vázquez-Del Mercado M, Casiano CA & Rubin RL (1995) Autoimmunity 20: 105–111
Matzinger P (1994) Annu. Rev. Immunol. 12: 991–1045
Jardetzky TS, Lane WS, Robinson RA & Wiley DC (1991) Nature 353: 326–329
Tan EM, Schur PH, Carr RI & Kunkel HG (1966) J. Clin. Invest. 45: 1732–1740
Tan EM, Chan EKL, Sullivan KF & Rubin RL (1988) Clin. Immunol. Immunopathol. 47: 121–141
Lefkowith JB & Gilkeson GS (1996) Arthritis Rheum. 39: 894–903
Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D & Theofilopoulos AN (1994) Proc. Natl. Acad. Sci. USA 91: 10160–10172
Kramers C, Hylkema MN, vanBruggen MCJ, van deLagemaat R, Dijkman HBP, Assmann KJM, Smeenk RJT & Berden JHM (1994) J. Clin. Invest. 94: 568–577
DiValerio R, Bernstein KA, Varghese E & Lefkowith JB (1995) J. Immunol. 155: 2258–2268
Bernstein KA, DiValerio R & Lefkowith JB (1995) J. Immunol. 154: 2424–2433
Rumore PM & Steinman CR (1990). J. Clin. Invest. 86: 69–74
Budhai L, Oh K & Davidson A (1996) J. Clin. Invest. 98: 1585–1593
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Burlingame, R.W., Rubin, R.L. Autoantibody to the nucleosome subunit (H2A-H2B)-DNA is an early and ubiquitous feature of lupus-like conditions. Molecular Biology Reports 23, 159–166 (1996). https://doi.org/10.1007/BF00351164
Issue Date:
DOI: https://doi.org/10.1007/BF00351164